FDA to remove Juul e-cigarettes from U.S. market in blow to Altria


Altria (MO) has a current dividend yield of 8.67% and is rated as “Borderline Safe” by SimplySafeDividends. I hold MO in my Low Yield Portfolio. In total MO is 0.6% of my portfolio.

The FDA could announce its decision as early as Wednesday, the people said. The marketing denial order would follow a nearly two-year review of data presented by the vaping company, which sought authorization for its tobacco- and menthol-flavored products to stay on the U.S. market.

Uncertainty has clouded Juul since it landed in the FDA’s sights four years ago, when its fruity flavors and hip marketing were blamed for fueling a surge of underage vaping. The company since then has been trying to regain the trust of regulators and the public. It limited its marketing and in 2019 stopped selling sweet and fruity flavors. Juul’s sales have tumbled in recent years.

The FDA has been conducting a review of U.S. vaping products, weighing their popularity with young people against their potential benefits as less harmful alternatives for adult cigarette smokers. All U.S. e-cigarette manufacturers in 2020 were required to submit their products for FDA review to stay on the market.

FDA to Order Juul E-Cigarettes Off U.S. Market – WSJ

Image by: http://www.altria.com/Responsibility/Governance-and-Compliance/Documents/Altria_Code_of_Conduct.pdf, Fair use, https://en.wikipedia.org/w/index.php?curid=18905956